Table 2: Patient characteristics of the TMA cohort.

From: Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features

TMA data set
CharacteristicsSummary
Lung adenocarcinoma patientsN=227
Age67.4±11.0 years
Gender41.4% Male; 58.6% female
Number of tumour histopathology image seriesN=227
Number of histopathology image tilesN=227
  
Grade
 Grades 135 (15.4%)
 Grades 1–20 (0%)
 Grade 2134 (59.0%)
 Grades 2–30 (0%)
 Grade 354 (23.8%)
 Grade 40 (0%)
 Grade unavailable4 (1.8%)
  
Stage
 Stage I121 (53.3%)
 Stage II64 (28.2%)
 Stage III41 (18.1%)
 Stage IV1 (0.4%)
 Stage unavailable0 (0%)
Lung squamous cell carcinoma patientsN=67
Age68.7±8.4 years
Gender62.7% Male; 37.3% female
Number of tumour histopathology image seriesN=67
Number of histopathology image tilesN=67
  
Grade
 Grade 14 (5.97%)
 Grade 1–20 (0%)
 Grade 233 (49.3%)
 Grade 2–30 (0%)
 Grade 328 (41.8%)
 Grade 3–40 (0%)
 Grade 41 (1.49%)
 Grade unavailable1 (1.49%)
Stage 
 Stage I36 (53.7%)
 Stage II25 (37.3%)
 Stage III6 (9.0%)
 Stage IV0 (0%)
 Stage unavailable0 (0%)
  1. Abbreviation: TMA, Stanford Tissue Microarray.